Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
xevinapant (Debio 1143)
i
Other names:
Debio 1143, AT-406, AT406, AT 406, Debio-1143, SM-406, Debio1143, SM406, SM 406
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Ascenta, Ascentage Pharma, Debiopharm, EMD Serono
Drug class:
IAP antagonist
Related drugs:
‹
27 (0)
BGB-24714 (0)
Comp 3 (0)
MV1 (0)
SM-164 (0)
TQB3728 (0)
27 (0)
BGB-24714 (0)
Comp 3 (0)
MV1 (0)
SM-164 (0)
TQB3728 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Squamous Cell Carcinoma of Head and Neck
No biomarker
Squamous Cell Carcinoma of Head and Neck
Debio 1143
Sensitive: B - Late Trials
Debio 1143
Sensitive
:
B
Debio 1143
Sensitive: B - Late Trials
Debio 1143
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login